Henagliflozin in Relieving Type 2 Diabetes With Non-alcoholic Fatty Liver Disease
NCT06218342
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
156
Enrollment
OTHER
Sponsor class
Conditions
Type 2 Diabetes
Non-Alcoholic Fatty Liver Disease
Interventions
DRUG:
Henagliflozin
OTHER:
Background medication
Sponsor
Sir Run Run Shaw Hospital